Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/3018% below fair value
$310.55+3.74 (+1.22%)
Close on Nov 3, 2026Market cap $119.12BP/E 33.1Yield –
Stryker Neuro Cranial by Quarter
Neuro Cranial (Legacy Standalone through FY2025Q3) — U.S. Net Sales ($M) ($M)
Stryker Neuro Cranial: $524M in Q3 2025, up 43.2% from a year earlier. That is the highest of the 15 quarters on record here.
Latest, Q3 2025
524
Period ended Sep 30, 2025
Change on a year earlier
+43.2%
366 in Q3 2024
History
15 quarters
Since Q1 2021
Sources
12
Documents cited below
Where the Q3 2025 figure comes from
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Stryker Neuro Cranial ($M), quarterly Q1 2021–Q3 2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/leg-nc-us-rev
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.
See a number that looks wrong?